FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Jeffrey Kindler news from FierceBiotech

News

SPOTLIGHT: Investors, analysts not impressed with Pfizer

Investors and analysts are none too impressed with Pfizer's new strategies as outlined by CEO Jeffrey Kindler and other execs during an annual Wall Street update yesterday. The stock fell to within Read more...

Pfizer seeks salvation in late-stage biotherapeutics

Pfizer's Jeff Kindler (photo) has boldly staked out plans to make 15 to 20 Read more...

SPOTLIGHT: Is Pfizer's CEO as bold as promised?

Like natives encountering a strange explorer in an old B movie, investors hailed Jeffrey Kindler (photo) when he was picked to succeed Pfizer CEO Read more...
Tags: Pfizer   Jeffrey Kindler  

Pfizer hires new R&D chief, launches biotech center

Pfizer is making moves to salvage its troubled pipeline. The company has named Martin Mackay as its new Read more...

Pfizer shows the door to two top executives

Jeffrey Kindler's plans to shake up Pfizer have led to the departure of two top executives. John LaMattina, global head of research, will retire and Alan Levin resigned as chief financial officer, Read more...

Pfizer's Kindler leaves analysts feeling flat

Wall Street's eyes were focused on Jeffrey Kindler today as Pfizer's new CEO stepped up to unveil its quarterly profits. Those profits soared 112 percent on increased drug revenue. But Pfizer now Read more...

Get more Jeffrey Kindler coverage at: